Paul Kwon
Overview
Paul Kwon received $893K in total compensation, including $412K in salary, at VYNE Therapeutics in 2019.
Source: SEC filing on June 22, 2020.
Related executives
We found seven more executives who work or worked at VYNE Therapeutics.
David Domzalski
VYNE Therapeutics
Chief Executive Officer
Iain Stuart
VYNE Therapeutics
Chief Scientific Officer
Mutya Harsch
VYNE Therapeutics
Chief Legal Officer
Steven Basta
VYNE Therapeutics
Chief Executive Officer
Andrew Saik
VYNE Therapeutics
Chief Financial Officer
Kristine Ball
VYNE Therapeutics
Chief Financial Officer
Mary Spellman
VYNE Therapeutics